Editorial: ‘Fixing’ drug prices
Herald Staff
Saturday, April 09, 2016
There is a breed of Massachusetts lawmaker who truly believes that there is a legislative solution to every problem
Yes, some life-saving drugs have started out being enormously expensive. Both the Health Policy Commission and Pioneer looked at the impact of the trailblazing drug Sovaldi, used to treat — and usually cure — hepatitis C, but at a cost of about $84,000 per course of treatment. The commission blamed the drug in part for a 13 percent hike in health care costs. But even at that price the drug was considered a bargain compared to, say, a liver transplant.
But, as Pioneer reported, when the federal government approved a second hep C treatment, the manufacturer of Sovaldi was forced
Continue reading....
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
No comments:
Post a Comment